PhD (1985) in Biology, Professor of Microbiology (University of Navarra, Pamplona). He was postdoctoral researcher at the Department of Molecular & Cellular Biology (University of California - Berkeley) and at the Department of Molecular Microbiology & Immunology (University of Columbia, Missouri). His interests are the animal and human brucellosis with emphasis on the genetic and phenotypic characterization of virulence factors, the construction of new live vaccines and the development of new molecular techniques for diagnosis and typing of Brucella.
An innovative group of 30 international education professionals taught the first online microbiology course using Twitter, #microMOOCSEM, complete with lectures, videos, news, and more, with some classes reaching over 260,000 impressions and 3,700 retweets. Currently, most students are users of social networks like YouTube, Facebook or Twitter and have incorporated them, often unconsciously as powerful […]
Listeria monocytogenes is a food-borne Gram positive bacteria that causes the infection listeriosis. It is responsible for serious clinical manifestations including gastroenteritis, and meningitis and encephalitis in newborns, with 20 to 30 % of clinical infections resulting in death. It is a facultative intracellular pathogen that can invade and move within eukaryotic cells by polymerization […]
LPS core mutants open the way for more effective brucellosis vaccines Brucellosis is a worldwide extended infectious disease of livestock (sheep, goats, cattle, cows, pigs, …) and remains one of the most common zoonotic infections, with more tan 500,000 new human cases worldwide every year. “ Brucellosis is a threat to human health and a […]
Few weeks ago, a new report by WHO reveals that antibiotic resistance is now a major threat to global public health: “ the world is headed for a post-antibiotic era ”. One of the priorities is the treatment of urinary tract infections caused by Escherichia coli strains isolated from several countries and which are resistant […]
Tuberculosis (TB) represents a serious public health problem. The latest reports estimate an incidence of 8.7 million cases in 2001 and over 1.4 million deaths per year. The disease is usually be treated with a first-line drugs, isoniazid and rifampin, the two most potent anti-tuberculosis agents. However, the prevalence of multidrug-resistant (MDR) tuberculosis cause by […]